Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Medication-Assisted Therapy Is More Than Just Buprenorphine

By Evan Schwarz, MD, FACEP, FACMT; and R. Corey Waller, MD, MS, FACEP, DFASAM | on January 14, 2019 | 0 Comment
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Medication-Assisted Therapy Is More Than Just Buprenorphine

Editor’s Note: This is the sixth part of an ongoing series on what emergency physicians can do to combat the opioid epidemic.

You Might Also Like
  • ED-Initiated Medication-Assisted Therapy: 1 Hospital’s Experience
  • Reader Raises 2 Issues with Buprenorphine Article
  • Buprenorphine Explained, And Opioid Addiction Treatment Tips
Explore This Issue
ACEP Now: Vol 38 – No 01 – January 2019

Plenty has been written and said about buprenorphine recently, and that’s not a bad thing.1–3 It’s a medication that can be started from the emergency department under the correct circumstances. It’s also a medication that a lot of us probably weren’t very familiar with, so many likely benefited from a crash course on bup. Of course, it is important to remember that medication-assisted therapy (MAT) involves more than just buprenorphine. In fact, there are two other medications patients can choose: methadone and naltrexone. Are emergency physicians likely to start patients on either of these medications from the emergency department? Absolutely not, although from what I’m told, some emergency departments have been using intramuscular methadone for opioid withdrawal for quite some time. Either way, given the emphasis on treatment of opioid use disorder (OUD) with medications, there is a fair chance we’ll start seeing more patients on these agents. As such, it is important that we have a basic understanding of them and how they could affect emergency physicians’ practice.

Also, it is worth noting that while we’ll continue to use the term MAT because most of us are familiar with it, the term is falling out of favor because some feel it inappropriately deemphasizes the role that medication plays in recovery for this population.

Methadone

Methadone has been the mainstay in the treatment of OUD long before buprenorphine became the cool kid on the block. While there is a ton of stigma associated with it and the word swirls with all sorts of negative connotations, methadone has been very successful in treating patients with OUD.4 It is a full agonist without a ceiling effect like buprenorphine, which means that it can be particularly dangerous. This is one reason it is so tightly regulated, at least for addiction. While it can be prescribed for pain, it cannot be prescribed for addiction. Patients must go to a properly licensed treatment center (e.g., a methadone clinic) where it can be dispensed under a physician’s supervision.

At the clinic, methadone is generally dispensed once a day, although toward the end of pregnancy, patients may receive twice-per-day dosing. If you’re boarding a patient with an OUD, don’t be fooled if they tell you that they get the medication three times per day, which a few of my floor patients have tried in the past. If the center is open or has an on-call number, you can verify the dose and frequency.

What about just doing a quick search of the prescription drug monitoring program (PDMP)? This seems easier than trying to hunt down the methadone clinic and awaiting a return call. Unfortunately, this won’t work. Since methadone is dispensed by these facilities, no prescription is ever written. While this may seem like semantics, it means this information is never loaded into the PDMP, so it won’t be there when you search. Sensing this was a problem, the ACEP Council passed a resolution in 2018 to have methadone included in the PDMP.5

As mentioned previously, methadone must be respected. It is potent, with a very long half-life, which means it can easily cause respiratory depression. Commonly, this occurs on days two through four if the medication is titrated too quickly. Fortunately, it doesn’t necessarily require large doses of naloxone to reverse it. In fact, 0.04 mg of naloxone may be enough.6 Patients can recrudesce, and this does not always happen quickly. I’ve had a quite a few who went down even four hours after their first dose of naloxone. These patients will require prolonged observation and possibly a naloxone infusion.

Keep in mind that the standard urine drug screen does not pick up methadone and can’t be relied on to rule out a methadone overdose. It won’t pick up buprenorphine or fentanyl either, making this test even more useless.

Methadone also causes a prolonged QTc. Does this mean everyone on methadone needs an ECG? No, it does not, and at low doses, such as 20–40 mg/day, methadone probably does not have a significant effect.7 However, some patients are on doses of more than 100 mg/day. In this case, you may want to consider an alternative to medications in the emergency department that cause QTc prolongation or at least obtain an ECG prior to ordering these medications.

What about your patient on methadone that is NPO? I’d recommend cutting the oral dose by at least half.8,9 For patients on methadone with acute pain, the dose should not be increased in the emergency department. In future columns, we’ll tackle acute pain control in patients on MAT.

Pages: 1 2 3 | Single Page

Topics: Opioid CrisisOpioid EpidemicPain and Palliative Care

Related

  • How to Manage Elderly Patient Pain without Opioids

    February 13, 2024 - 0 Comment
  • Are Opiates Futile in Low Back Pain?

    October 15, 2023 - 0 Comment
  • September 2023 News from the College

    August 29, 2023 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

No Responses to “Medication-Assisted Therapy Is More Than Just Buprenorphine”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603